4.7 Article

The TRC8 E3 ligase ubiquitinates MHC class I molecules before dislocation from the ER

Journal

JOURNAL OF CELL BIOLOGY
Volume 186, Issue 5, Pages 685-692

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.200906110

Keywords

-

Categories

Funding

  1. Medical Research Council
  2. Wellcome Trust
  3. Newton Trust
  4. Cambridge Biomedical Research Centre
  5. MRC [G9800943, G0600823] Funding Source: UKRI
  6. Medical Research Council [G9800943, G0600823] Funding Source: researchfish

Ask authors/readers for more resources

The US2 and US11 gene products of human cytomegalovirus promote viral evasion by hijacking the endoplasmic reticulum (ER)-associated degradation (ERAD) pathway. US2 and US11 initiate dislocation of newly translocated major histocompatibility complex class I (MHC I) from the ER to the cytosol for proteasome-mediated degradation, thereby decreasing cell surface MHC I. Despite being instrumental in elucidating the mammalian ERAD pathway, the responsible E3 ligase or ligases remain unknown. Using a functional small interfering RNA library screen, we now identify TRC8 ( translocation in renal carcinoma, chromosome 8 gene), an ER-resident E3 ligase previously implicated as a hereditary kidney cancer gene, as required for US2-mediated MHC I ubiquitination. Depletion of TRC8 prevents MHC I ubiquitination and dislocation by US2 and restores cell surface MHC I. TRC8 forms an integral part of a novel multiprotein ER complex that contains MHC I, US2, and signal peptide peptidase. Our data show that the TRC8 E3 ligase is required for MHC I dislocation from the ER and identify a new complex associated with mammalian ERAD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available